Today, the Chan Zuckerberg Initiative (CZI) announced the launch of a new biomedical research hub in Chicago, Illinois that will bring together leading scientific and technology institutions with the goal of solving grand scientific challenges on a 10- to 15-year time horizon. The Chan Zuckerberg Biohub Chicago will catalyze collaboration between the University of Chicago, Northwestern University, and the University of Illinois Urbana-Champaign to develop new technologies for studying and measuring human biology that will use embedded sensors and probes to collect biological signals from human tissues with unprecedented resolution.

“Amazing news that Chicago was named as the home for the next Chan Zuckerberg Biohub. This announcement reflects the leadership of our world class research institutions and our community’s position as an innovation leader in the life sciences.” John Conrad, iBIO President & CEO, “This forward-thinking partnership brings together some of the most brilliant minds from Northwestern University, The University of Chicago and University of Illinois Urbana-Champaign. Combining their unique strengths will accelerate the pace of discoveries and make a substantive impact on medicine and healthcare.”

Read the full news story here